Pharma Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Centers for Disease Control & Prevention, U.S.
HIV RNA testing improves diagnosis of HIV infection in high-risk patients
July 4th, 2006
HIV RNA testing improves the diagnosis of acute HIV infections in high-risk patients in California. According to recent research from the United States, "Given the strong relationship between sexually transmitted diseases (STDs) and the spread of HIV infection, recent outbreaks of syphilis in the United States could lead to increased rates of new HIV infection. STD clinics serving persons at risk for syphilis would be logical sites to monitor rates of acute HIV infection. The detection of acute HIV infection, however, is not routine and requires the use of HIV RNA testing in combination with HIV antibody testing." "To determine the rate of acute HIV...
Source: Pharma Law Weekly (2006-07-04)
|
